Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.6176
+0.0346 (5.93%)
At close: Oct 15, 2026, 4:00 PM EDT
0.6250
+0.0074 (1.20%)
After-hours: Oct 15, 2026, 7:23 PM EDT
APRE's stock price has decreased by -59.1% in the past year and price targets may not have had time to catch up.
Aprea Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ladenburg Thalmann & Co. | Ladenburg Thalmann & Co. | Buy Initiates $2 | Buy | Initiates | $2 | +223.83% | Oct 14, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $5 | Buy | Reiterates | $5 | +709.59% | Aug 14, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $5 | Buy | Reiterates | $5 | +709.59% | Aug 13, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $1.2 | Buy | Reiterates | $1.2 | +94.30% | Aug 13, 2026 |
| Wedbush | Wedbush | Buy Reiterates $7 → $6 | Buy | Reiterates | $7 → $6 | +871.50% | May 14, 2026 |